To assess the safety and effectiveness of telmisartan/amlodipine in comparison to telmisartan in Indian patients with hypertension through a real-world, retrospective, Observational study (CONTROL Study)

This is a real-world, retrospective, observational, open-label study with an objective to evaluate the tolerability and effectiveness of telmisartan and amlodipine combination in comparison to telmisartan monotherapy as initial-line therapy in treatment-naïve Indian adults with newly diagnosed hypertension.

The Endpoints of the study are as follows-

1. Primary Endpoints:

• Mean change in seated SBP & DBP from baseline at 12±2 weeks

2. Secondary Endpoints:

• Proportion of patients achieving BP control (defined as mean seated SBP <130 mmHg and DBP <80 mmHg) at 12±2 weeks.

• Proportion of patients who sustained or improved on BP control achieved at 12±2 weeks over 24±2 weeks

• Incidence of adverse events

Data of approximately 14,000 patients across India will be collected for the purpose of this study. The available data must meet all the following criteria to be included in the study:

1. Inclusion Criteria

• Adult Male or female patients with newly diagnosed hypertension (BP >140/90 mmHg)

• Patients diagnosed with hypertension and treated with telmisartan & amlodipine combination or telmisartan monotherapy as initial line therapy

2. Exclusion Criteria

• Patients with current or past exposure to antihypertensive medications other than study drug